tiprankstipranks
Advertisement
Advertisement

KURA Stock Latest News

Zhu Reiterates Buy on Ziftomenib Developer, Citing Strong Phase 1 AML Data and Favorable Safety Profile; Price Target Maintained at $28
RatingsZhu Reiterates Buy on Ziftomenib Developer, Citing Strong Phase 1 AML Data and Favorable Safety Profile; Price Target Maintained at $28
26d ago
KURA
Syndax price target lowered to $31 from $34 at Guggenheim
PremiumThe Fly
Syndax price target lowered to $31 from $34 at Guggenheim
29d ago
KURA
SNDX
Kura Oncology Advances Targeted Combo in Tough Head and Neck Cancer
PremiumCompany Announcements
Kura Oncology Advances Targeted Combo in Tough Head and Neck Cancer
1M ago
KURA
Kura Oncology Shareholders Approve Expanded Equity Incentive Plans
PremiumCompany Announcements
Kura Oncology Shareholders Approve Expanded Equity Incentive Plans
1M ago
8K
KURA
Analyst Reiterates Buy on Kura Oncology, Maintains $40 Price Target on Expanding Darlifarnib Combination Platform
PremiumRatings
Analyst Reiterates Buy on Kura Oncology, Maintains $40 Price Target on Expanding Darlifarnib Combination Platform
1M ago
KURA
Kura reports data supporting darlifarnib potential for KRAS-mutant cancers
PremiumThe FlyKura reports data supporting darlifarnib potential for KRAS-mutant cancers
1M ago
KURA
Kura Oncology reports first-in-human data from the FIT-001 clinical trial
Premium
The Fly
Kura Oncology reports first-in-human data from the FIT-001 clinical trial
2M ago
KURA
Kura Oncology: Buy Rating Reiterated as Early Darlifarnib/Adagrasib Data Support Favorable Risk-Reward and $40 Price Target Maintained
Premium
Ratings
Kura Oncology: Buy Rating Reiterated as Early Darlifarnib/Adagrasib Data Support Favorable Risk-Reward and $40 Price Target Maintained
2M ago
KURA
Kura Oncology Earnings Call Signals Early Launch Strength
PremiumCompany Announcements
Kura Oncology Earnings Call Signals Early Launch Strength
2M ago
KURA
Kura Oncology Earnings Call Highlights Comzifty Momentum
PremiumCompany Announcements
Kura Oncology Earnings Call Highlights Comzifty Momentum
2M ago
KURA
Closing Bell Movers: Karman falls over 10% after Q1 earnings miss
PremiumThe Fly
Closing Bell Movers: Karman falls over 10% after Q1 earnings miss
2M ago
AIP
INR
Kura Oncology reports Q1 EPS (83c), consensus (78c)
PremiumThe Fly
Kura Oncology reports Q1 EPS (83c), consensus (78c)
2M ago
KURA
Kura, Kyowa Kirin to present updated frontline data from Phase 1 KOMET-007 trial
PremiumThe FlyKura, Kyowa Kirin to present updated frontline data from Phase 1 KOMET-007 trial
2M ago
KURA
Kura Oncology: Early Darlifarnib Kidney Cancer Data Validate FTI Strategy and Underscore Attractive Risk‑Reward Upside
Premium
Ratings
Kura Oncology: Early Darlifarnib Kidney Cancer Data Validate FTI Strategy and Underscore Attractive Risk‑Reward Upside
3M ago
KURA
Kura Oncology: Compelling Darlifarnib–Cabozantinib Data in Post-IO RCC Support Continued Buy Rating
Premium
Ratings
Kura Oncology: Compelling Darlifarnib–Cabozantinib Data in Post-IO RCC Support Continued Buy Rating
3M ago
KURA
Kura Oncology reports results from ongoing FIT-001 clinical trial
PremiumThe Fly
Kura Oncology reports results from ongoing FIT-001 clinical trial
3M ago
KURA
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
3M ago
ANGX
IMRX
Kura Oncology initiated with a Buy at Lake Street
PremiumThe Fly
Kura Oncology initiated with a Buy at Lake Street
3M ago
KURA
Syndax assumed with a Buy at Jefferies
PremiumThe Fly
Syndax assumed with a Buy at Jefferies
3M ago
KURA
SNDX
Kura Oncology price target lowered to $25 from $30 at Mizuho
PremiumThe FlyKura Oncology price target lowered to $25 from $30 at Mizuho
4M ago
KURA
Kura Oncology price target lowered to $15 from $16 at UBS
Premium
The Fly
Kura Oncology price target lowered to $15 from $16 at UBS
4M ago
KURA
Kura Oncology price target raised to $30 from $29 at BofA
Premium
The Fly
Kura Oncology price target raised to $30 from $29 at BofA
4M ago
KURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >